- Home
- NAMS vs AVNT Comparison
NAMS vs AVNT Comparison
Compare NAMS & AVNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAMS | AVNT |
|---|---|---|
| Founded | 2019 | 1927 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.9B |
| IPO Year | N/A | 1993 |
Fundamental Metrics
Financial Performance| Metric | NAMS | AVNT |
|---|---|---|
| Price | $34.68 | $30.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 6 |
| Target Price | ★ $45.80 | $45.67 |
| AVG Volume (30 Days) | ★ 1.1M | 745.8K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 3.49% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.23 |
| Revenue | $35,243,000.00 | ★ $3,246,100,000.00 |
| Revenue This Year | N/A | $2.24 |
| Revenue Next Year | N/A | $2.48 |
| P/E Ratio | ★ N/A | $25.16 |
| Revenue Growth | ★ 4.91 | 1.03 |
| 52 Week Low | $14.06 | $27.48 |
| 52 Week High | $42.00 | $49.23 |
Technical Indicators
Market Signals| Indicator | NAMS | AVNT |
|---|---|---|
| Relative Strength Index (RSI) | 42.09 | 48.79 |
| Support Level | $34.59 | $29.86 |
| Resistance Level | $37.41 | $31.83 |
| Average True Range (ATR) | 1.79 | 0.83 |
| MACD | -0.40 | 0.11 |
| Stochastic Oscillator | 1.97 | 26.46 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About AVNT Avient Corporation
Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.